Literature DB >> 23737244

Sexual dysfunction related to psychotropic drugs: a critical review part II: antipsychotics.

A La Torre1, A Conca, D Duffy, G Giupponi, M Pompili, M Grözinger.   

Abstract

Sexual dysfunction is a potential side effect of antipsychotic drugs: this article presents a critical review of the current literature. Although many studies have been published on the subject, only some used a validated sexual function rating scale and most lacked either a baseline or placebo control or both. In addition, many of the studies on sexual dysfunction associated with antipsychotic medication are limited by other methodological flaws. However, there is consistent evidence to suggest that a large number of antipsychotic drugs adversely affect one or more of the 3 phases of sexual response (desire, arousal and orgasm). Among the antipsychotics, the so called "prolactin-raising" are probably most associated with sexual dysfunction, even if further studies to confirm this are needed: the reviewed literature shows no consistent evidence that any one antipsychotic drug has a significantly superior side effect profile over another and current information on this topic is often based on methodologically weak research. Clinicians must be aware of drug-induced sexual dysfunction, since its presence can have important consequences for clinical management and compliance. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23737244     DOI: 10.1055/s-0033-1347177

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN: 0176-3679            Impact factor:   5.788


  9 in total

1.  Bringing the body of the iceberg to the surface: the Female Sexual Dysfunction Index-6 (FSDI-6) in the screening of female sexual dysfunction.

Authors:  E Maseroli; E Fanni; M Fambrini; B Ragghianti; E Limoncin; E Mannucci; M Maggi; L Vignozzi
Journal:  J Endocrinol Invest       Date:  2015-09-03       Impact factor: 4.256

2.  Management of common adverse effects of antipsychotic medications.

Authors:  T Scott Stroup; Neil Gray
Journal:  World Psychiatry       Date:  2018-10       Impact factor: 49.548

Review 3.  Psychotropics and sexual dysfunction.

Authors:  Anthony J Bella; Rany Shamloul
Journal:  Cent European J Urol       Date:  2014-01-27

4.  Erotic stimulus processing under amisulpride and reboxetine: a placebo-controlled fMRI study in healthy subjects.

Authors:  Heiko Graf; Maike Wiegers; Coraline D Metzger; Martin Walter; Georg Grön; Birgit Abler
Journal:  Int J Neuropsychopharmacol       Date:  2014-10-31       Impact factor: 5.176

5.  Women's sexual dysfunction associated with psychiatric disorders and their treatment.

Authors:  Rosemary Basson; Thea Gilks
Journal:  Womens Health (Lond)       Date:  2018 Jan-Dec

6.  Recurrent Episodes of Paraphilic Behavior Possibly Associated With Olanzapine and Aripiprazole Treatment in a Patient With Schizophrenia.

Authors:  Maria-Ioanna Stefanou; Debora Vittore; Ines Wolz; Stefan Klingberg; Dirk Wildgruber
Journal:  Front Psychiatry       Date:  2020-04-20       Impact factor: 4.157

7.  Evaluation of sexual dysfunction and quality of life in patients with severe mental illness: A cross-sectional study from a tertiary care center in Chhattisgarh.

Authors:  Deepak Ghormode; Pramod Gupta; Devendra Ratnani; Jitender Aneja
Journal:  Ind Psychiatry J       Date:  2019-12-11

Review 8.  Management Strategies for Antipsychotic-Related Sexual Dysfunction: A Clinical Approach.

Authors:  Angel L Montejo; Rubén de Alarcón; Nieves Prieto; José Mª Acosta; Bárbara Buch; Laura Montejo
Journal:  J Clin Med       Date:  2021-01-15       Impact factor: 4.241

9.  Alprazolam-induced dose-dependent anorgasmia: case analysis.

Authors:  Kenneth R Kaufman; Melissa Coluccio; Michelle Linke; Elizabeth Noonan; Ronke Babalola; Rehan Aziz
Journal:  BJPsych Open       Date:  2018-07-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.